How Groundbreaking ADCs Are Helping More Patients With MBC How Groundbreaking ADCs Are Helping More Patients With MBC
The experts discuss current approaches in the sequencing of antibody-drug conjugates, which have been changing the treatment landscape for patients with metastatic breast cancer.Medscape Oncology
Source: Medscape Today Headlines - August 8, 2023 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

Drug Safety Communication: FDA warns about potential medication errors resulting from confusion regarding nonproprietary name for breast cancer drug Kadcyla (ado-trastuzumab emtansine)
The U.S. Food and Drug Administration (FDA) is alerting health care professionals that the use of the incorrect nonproprietary name for the breast cancer drug Kadcyla (ado-trastuzumab emtansine) in some medication-related electronic systems poses a risk of mix-up with Herceptin (trastuzumab) and may
Source: FDA Center for Drug Evaluation and Research - What's New - August 8, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Women Over 70 Risk Breast Cancer Overdiagnosis With Screening Women Over 70 Risk Breast Cancer Overdiagnosis With Screening
A new study is raising fresh questions about the value of breast cancer screening in older women.Reuters Health Information
Source: Medscape Medical News Headlines - August 8, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

I went for breast reduction surgery to downsize my size H boobs and left with five years to live - after surgeon found a stage 4 cancerous lump
Savannah White, 30, from Knoxville, Tennessee, claims reduction surgery on her size H breasts saved her life after surgeons discovered a 'fist-sized' lump that turned out to be stage IV cancer.
Source: the Mail online | Health - August 8, 2023 Category: Consumer Health News Source Type: news

Breast Cancer Screening May Not Be Worth It for Women Over 70
TUESDAY, Aug. 8, 2023 -- The risks of screening mammograms to catch breast cancer may outweigh the benefits for certain women aged 70 or older, new research indicates. The main risk? Overdiagnosis and treatment of a breast cancer that likely...
Source: Drugs.com - Daily MedNews - August 8, 2023 Category: General Medicine Source Type: news

Higher BPE on breast MRI suggests increased cancer risk
A machine learning model used with breast MR images shows that higher level...Read more on AuntMinnie.comRelated Reading: MRI radiomics features predicts breast cancer tumor expressions Surveillance imaging should be tailored for breast tumor subtypes CEM on par with breast MRI in lobular breast cancer staging ACR releases updated breast cancer screening recommendation PET/MRI cuts breast cancer scan times in half
Source: AuntMinnie.com Headlines - August 8, 2023 Category: Radiology Source Type: news

Episode 5: Health Disparities in Advanced and Metastatic Breast Cancer Episode 5: Health Disparities in Advanced and Metastatic Breast Cancer
Drs Banu Arun and Stephanie Graff discuss drug access, clinical trials, and health disparities in advanced and metastatic breast cancer, and inclusion-based solutions for physicians and institutions.Medscape
Source: Medscape Today Headlines - August 8, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news

Ductal Carcinoma in Situ (DCIS): What It Is, Causes, Symptoms & Treatment
A breast cancer diagnosis can be terrifying, but one type of early-stage disease is noninvasive and has high survival odds. There have been an estimated 297,790 new cases of breast cancer diagnosed in the United States so far this year, the U.S....
Source: Drugs.com - Daily MedNews - August 8, 2023 Category: General Medicine Source Type: news

Understanding the Stages of Breast Cancer: 0, 1, 2, 3 & 4
A diagnosis of breast cancer comes with many tough questions, but one of the biggest is what stage your cancer is. Millions of women struggle with such questions every year: Breast cancer is the most common cancer in women in the United States, with...
Source: Drugs.com - Daily MedNews - August 8, 2023 Category: General Medicine Source Type: news

Elderly women at risk of breast cancer overdiagnosis
Elderly women who undergo routine screening mammography for breast cancer ar...Read more on AuntMinnie.comRelated Reading: Women prefer mammography surveillance for low-risk DCIS Can AI risk assessment improve screening mammography results? Should elderly breast cancer survivors still get mammograms? Most older breast cancer survivors still receive annual mammograms Breast screening rates fall for older women in ACOs
Source: AuntMinnie.com Headlines - August 7, 2023 Category: Radiology Source Type: news

Radiologist on Damar Hamlin care team speaks with AuntMinnie.com
Carl Flink, MD, from UC Health spoke with AuntMinnie.com about hi...Read more on AuntMinnie.comRelated Reading: AI proves useful in the emergency department for detecting fractures Could phone tree system help with radiologist burnout? Ultralow-dose CT and x-ray match in emergency department study Abbreviated MRI protocols effective for emergency applications Urgent care settings may offer breast cancer screening opportunity
Source: AuntMinnie.com Headlines - August 7, 2023 Category: Radiology Source Type: news

Breast Cancer Overdiagnosis Risk May Be Substantial for Older Women
(MedPage Today) -- Older women screened for breast cancer were at a considerable risk of being overdiagnosed, according to a large retrospective cohort study. Researchers found that an estimated 31% of breast cancers among screened women from...
Source: MedPage Today Public Health - August 7, 2023 Category: American Health Source Type: news

PPIs May Curb Benefits of Palbociclib in Breast Cancer PPIs May Curb Benefits of Palbociclib in Breast Cancer
Concomitant use of a proton pump inhibitor with the CDK4/6 inhibitor palbociclib in women with advanced breast was associated with worse PFS and overall survival, a retrospective analysis shows.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - August 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Where You Live Can Shape How Alzheimer ’ s Affects You
The FDA in mid-July for the first time ever approved an Alzheimer’s drug, Leqembi. The annual price-tag will run patients $26,500. The same week, the Alzheimer’s Association for the first time ever released county-level data to identify which communities are most struggling with the disease. 6.7 million Americans live with Alzheimer’s disease and 134,000 of them will die because of it each year. We’ve known these aggregate numbers for a while now, but with new data and new drugs, healthcare specialists can now better target attention and resources. [time-brightcove not-tgx=”true”] ...
Source: TIME: Health - August 7, 2023 Category: Consumer Health News Authors: Jeremy Ney Tags: Uncategorized freelance Source Type: news

Women prefer mammography surveillance for low-risk DCIS
Active surveillance with mammography is the go-to choice for most women wit...Read more on AuntMinnie.comRelated Reading: AI doesn't improve breast cancer screening in dense breasts AI helps characterize breast microcalcifications SBI: DCIS progression appears as new masses on surveillance imaging Half of DCIS-treated women don't get ongoing imaging surveillance Is palpable DCIS more aggressive than screen-detected?
Source: AuntMinnie.com Headlines - August 7, 2023 Category: Radiology Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20